Search results
Showing 6406 to 6420 of 8314 results
BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain (MTG4)
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
This advice has been updated and replaced by NICE diagnostics guidance 34.
This advice has been updated and replaced by NICE medical technologies guidance 47.
AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)
This advice has been updated and replaced by NICE medtech innovation briefing 232.
Self-harm in over 8s: short-term management and prevention of recurrence (CG16)
This guidance has been updated and replaced by NICE guideline NG225.
Fever in under 5s: assessment and initial management (CG160)
This guidance has been updated and replaced by NICE guideline NG143.
This guidance has been updated and replaced by NICE guideline NG236.
This guidance has been updated and replaced by NICE guideline CG41.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)
This guidance has been updated and replaced by NICE guideline NG158.
This advice has been updated and replaced by NICE guideline NG199.
This evidence summary has been updated and replaced by NICE advice ESNM26.
This evidence summary has been withdrawn because the product is no longer available in the UK.
Acute diarrhoea in children: racecadotril as an adjunct to oral rehydration (ESNM12)
This evidence summary has been withdrawn because the product is no longer available in the UK.
Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)
This evidence summary has been updated and replaced by NICE guideline NG117.
Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)
This evidence summary has been updated and replaced by NICE guideline NG101.